S69glC21

N/A

Report date: 2024/08/08 09:27:53

Base Information

Drug NameS69glC21
Drug Alias NameS69glC21S-69-glC-21
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEndothelin receptor type A antagonists
TargetsEndothelin receptor type A
Therapy Area/IndicationsCardiovascular DiseasesKidney DiseasesLung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsCardiovascular DiseasesKidney DiseasesLung Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A